According to Alexandria Real Estate Equities 's latest financial reports the company's total liabilities are $14.94 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $14.14 B | 10.19% |
2022-12-31 | $12.84 B | 14.79% |
2021-12-31 | $11.18 B | 19.2% |
2020-12-31 | $9.38 B | 14.11% |
2019-12-31 | $8.22 B | 25.17% |
2018-12-31 | $6.57 B | 16.89% |
2017-12-31 | $5.62 B | 13.03% |
2016-12-31 | $4.97 B | 8.41% |
2015-12-31 | $4.58 B | 8.53% |
2014-12-31 | $4.22 B | 19.03% |
2013-12-31 | $3.55 B | -2.64% |
2012-12-31 | $3.64 B | 16.1% |
2011-12-31 | $3.14 B | 7.59% |
2010-12-31 | $2.91 B | -4.31% |
2009-12-31 | $3.05 B | -10.02% |
2008-12-31 | $3.39 B | 8.05% |
2007-12-31 | $3.13 B | 42.11% |
2006-12-31 | $2.20 B | 46% |
2005-12-31 | $1.51 B | 20.83% |
2004-12-31 | $1.25 B | 63.54% |
2003-12-31 | $0.76 B | 13.67% |
2002-12-31 | $0.67 B | 6.97% |
2001-12-31 | $0.62 B |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $137.21 B | 818.24% | ๐บ๐ธ USA |
Eli Lilly LLY | $51.04 B | 241.60% | ๐บ๐ธ USA |
Amgen AMGN | $90.92 B | 508.45% | ๐บ๐ธ USA |
Gilead Sciences GILD | $39.37 B | 163.51% | ๐บ๐ธ USA |
Illumina ILMN | $4.36 B | -70.78% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $82.48 B | 451.98% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | $4.04 B | -72.94% | ๐บ๐ธ USA |